8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2018 / Single-centre, open-label, fixed-sequence trial
Twelve healthy Chinese volunteers received a single 8 mg dose of blonanserin while fasting, with a high-fat meal, or with 250 mL of grapefruit juice across three periods with a 7-day washout. High-fat meals significantly increased blonanserin AUCt 2.58-fold (90% CI 2.21, 3.02) compared to fasting. Co-administration with grapefruit juice prolonged the elimination half-life of blonanserin from 9.7 to 21.4 hours and increased exposures to blonanserin and its metabolite by 5.82-fold (90% CI 4.57, 7.42) and 1.81-fold (90% CI 1.65, 1.98), respectively.
Shang DW, Wang ZZ, Hu HT, et al. Eur J Clin Pharmacol, 2018. PMID 28975417
1993 / Three-way crossover study
Twelve healthy volunteers on a controlled aluminium (Al) diet consumed a tea infusion (500 ml/70 kg body weight) with milk, with lemon juice, or mineral water across a three-way crossover design. Plasma Al concentrations were measured before and up to 24 hours after consumption. Intake of up to 1.60 mg Al from tea with milk or lemon juice did not raise plasma Al levels compared with drinking mineral water containing approximately 0.001 mg Al.
Drewitt PN, Butterworth KR, Springall CD, et al. Food Chem Toxicol, 1993. PMID 8444383
1993 / Intervention trial with in vitro microsomal component
Researchers evaluated the effects of grapefruit juice and naringenin on human CYP1A2 activity using caffeine as a probe substrate. In vitro, naringin competitively inhibited caffeine 3-demethylation by human liver microsomes (Ki = 7-29 microM). In vivo among 12 participants, grapefruit juice (1.2 l day-1 containing 0.5 g l-1 naringin) decreased oral caffeine clearance by 23% (95% CI: 7%-30%) and prolonged its half-life by 31% (95% CI: 20%-44%). The authors concluded that while grapefruit juice inhibits CYP1A2, the small in vivo effect suggests it generally should not cause clinically significant inhibition of other CYP1A2 drug substrates.
Fuhr U, Klittich K, Staib AH Br J Clin Pharmacol, 1993. PMID 8485024
1986 / Randomized controlled trial
Ten subjects with normal renal function took single doses of aluminium-containing antacids (1, 4, or 8 tablets containing 244 mg aluminium per tablet) with water, orange juice, or citric acid solution. Serum aluminium increased markedly when antacids were taken with citric acid (P < 0.001) or orange juice (P < 0.05), whereas taking them with water produced only a slight increase with 4 tablets. A significant increase in 24-hour urinary aluminium excretion followed all antacid doses. Estimated aluminium absorption was 8 and 50 times higher when antacids were taken with orange juice or citric acid, respectively, compared to water.
Weberg R, Berstad A Eur J Clin Invest, 1986. PMID 3100311
1986 / Experimental intervention trial
Ten healthy men ingested citric acid (as lemon juice), Al(OH)3, or Al(OH)3 plus citric acid twice daily between meals during 7-day periods. Mean whole blood aluminum concentrations increased from a pretreatment level of 5 (SD 3) micrograms/L to 9 (SD 4) micrograms/L after citric acid and 12 (SD 3) micrograms/L after Al(OH)3. Combined ingestion of Al(OH)3 and citric acid caused a more pronounced, highly significant increase to 23 (SD 2) micrograms Al/L (p < 0.001).
Slanina P, Frech W, Ekström LG, et al. Clin Chem, 1986. PMID 3948402